Biocartis Group NV Corporate Bonds and Leverage Analysis
BCART Stock | EUR 0.29 0.00 0.00% |
Biocartis Group NV has over 128.15 Million in debt which may indicate that it relies heavily on debt financing. With a high degree of financial leverage come high-interest payments, which usually reduce Biocartis Group's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Biocartis Group's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Biocartis Group's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Biocartis Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Biocartis Group's stakeholders.
For most companies, including Biocartis Group, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Biocartis Group NV, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Biocartis Group's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Biocartis |
Given the importance of Biocartis Group's capital structure, the first step in the capital decision process is for the management of Biocartis Group to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Biocartis Group NV to issue bonds at a reasonable cost.
Biocartis Group NV Debt to Cash Allocation
Biocartis Group NV has accumulated 128.15 M in total debt with debt to equity ratio (D/E) of 40.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Biocartis Group NV has a current ratio of 2.76, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Biocartis Group until it has trouble settling it off, either with new capital or with free cash flow. So, Biocartis Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biocartis Group NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biocartis to invest in growth at high rates of return. When we think about Biocartis Group's use of debt, we should always consider it together with cash and equity.
Biocartis Group Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Biocartis Group's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Biocartis Group, which in turn will lower the firm's financial flexibility.Biocartis Group Corporate Bonds Issued
Most Biocartis bonds can be classified according to their maturity, which is the date when Biocartis Group NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understaning Biocartis Group Use of Financial Leverage
Biocartis Group's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Biocartis Group's total debt position, including all outstanding debt obligations, and compares it with Biocartis Group's equity. Financial leverage can amplify the potential profits to Biocartis Group's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Biocartis Group is unable to cover its debt costs.
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. The company was founded in 2007 and is headquartered in Mechelen, Belgium. BIOCARTIS operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange. It employs 619 people. Please read more on our technical analysis page.
Other Information on Investing in Biocartis Stock
Biocartis Group financial ratios help investors to determine whether Biocartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biocartis with respect to the benefits of owning Biocartis Group security.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.